BioCentury
ARTICLE | Clinical News

DepoAmikacin: Began Phase I trial

January 2, 1996 8:00 AM UTC

DepoTech Corp. (DEPO), San Diego, Calif. Product: DepoAmikacin, sustained release form of the antibiotic amikacin in DepoFoam biodegradable encapsulating particles Indication: Treat and prevent local ...